Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

A KLK5 inhibitor effectively improved skin symptoms in a mouse model of Netherton Syndrome.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Dermal lymphatic vessels help hair growth by affecting hair cycle phases.

Finasteride reduces melanin production in skin cells.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Cardamonin reduces inflammation in gum tissue cells.

Reducing nerve growth can help skin regenerate after birth.

STAT3 reduces FST gene activity and cell growth, affecting hair development and wool quality.

Cyclosporin promotes hair growth by boosting cell growth and reducing cell death.

Finasteride reduces blood vessel formation in seminal vesicles.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

5α-reductase inhibitors, like Finasteride and Dutasteride, help manage benign prostatic hyperplasia.

Finasteride effectively treats BPH, but needs more trials to understand potential.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Finasteride safely lowers DHT levels without affecting testosterone.

Aging causes skin stem cells to work less effectively.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Testosterone's muscle-building effects do not require its conversion to DHT.